By 2015, adults aged 50 to 75 will make up 40 percent of the adult population. That has been a significant trend that has influenced the type of technologies startups are developing. A report by Start Up Health and the AARP revealed that investment in digital health companies that include technology of interest to Americans in the 50+ market rose 28 percent in the past year to $928 million by the end of the third quarter this year. But which categories attracted the most investment or saw the most deal activity? Here are a few indications.
Early-stage deals drove investment growth trends in the 50+ segment. The number of deals in this area have grown from $72 million in 2010 to $335 million by the end of September 2013.
Navigating the healthcare system attracted the most funding and deal activity — 78 deals generated $384 million in funding. Dr. Mehmet Oz and Jeff Arnold’s business Sharecare raised the most in this category with $68.2 million. Among its products, it offers a health risk assessment — the RealAge Test — and a social Q&A format tapping health and wellness experts to help “simplify” the search for information. Other notable investments in this category included Startup health insurer Oscar which raised $40 million, Pokitdoc netted $4 million and Caremerge which raised $2.1 million.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Vital sign monitoring had the largest average median deal size. Among the companies in this space, Proteus raised $62.5 million in a Series F round, Watermark Medical raised $32.2 million. Mc10 raised $18 million in a series D and Basis raised $11.5 million in a Series B round .
Emergency detection and response generated the second most deal growth. Intelomed raised $4 million in a series A, Podimetrics raised $2.5 million in a seed round, HotDot raised $3.2 million in a Series A, and Zephyr raised $2.5 million in a Series A.
Medication management/adherence is seen as an emerging category in digital health with companies such as My Meds and Me, MediSafe, ZappRx and HealthPrize.